Результаты поиска

Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.

BACKGROUND AND OBJECTIVES: Patients with autoimmune diseases (ADs) are at an increased risk of developing hematological malignancies (HMs). While allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative option for HMs, the outcomes in patients with concomitant ADs and the effects of transplantation on autoimmune conditions remain poorly characterized. METHODS: In this real-world study, we compared transplantation outcomes between 41 patients with HMs and preexisting ADs and 123 matched controls with HMs but without ADs. RESULTS: A total of 65.8% of the patients with ADs h

Совпадение в полном тексте источника
… Use of Large Language Models, AI and Machine Learning Tools : None declared. Data Availability Statement : The data generated in this study are available upon request from the corresponding author. References 1. Gutierrez-Arcelus M, Rich SS, Raychaudhuri S. …

Когнитивные дефекты у новых пациентов с множественным склерозом: систематический обзор соответствующих молекулярных биомаркеров и мета-анализ сопутствующих демографических и связанных с болезнями характеристик.

Фон/цели: Нейропсихологическое расстройство (НИ) характерно для недавно диагностированных пациентов с множественным склерозом (pwMS). Это исследование преследует две основные цели: систематический обзор направлен на описание взаимосвязи между НИ и молекулярными биомаркерами в недавно диагностированных PSM, а метаанализ направлен на изучение взаимосвязи между НИ, возрастом, статусом инвалидности и продолжительностью болезни в этой группе пациентов. Методы: Мы провели систематический обзор, в ходе которого 20 исследований отвечали критериям охвата. Из них 12 исследований были включены в метаанал

Beyond CAR T-Cell Therapy: Continued Monitoring and Management of Complications.

Chimeric antigen receptor (CAR) T-cell therapy has recently emerged as a groundbreaking treatment for CD19-expressing hematologic malignancies and received rapid approval by the U.S. Food & Drug Administration. Tisagenlecleucel and axicabtagene ciloleucel are now widely available at CAR T-cell therapy centers around the United States. Many patients have achieved complete response or remission despite failing multiple previous lines of therapy, but some patients endure the severe risks of cytokine release syndrome, neurotoxicity, and other immunologic effects. As more patients receive this ther

Abstracts from the 13th International Conference for Healthcare and Medical Students (ICHAMS).

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… OS4 Using artificial intelligence to generate medical literature for patients: a comparison of three different large language models David Pompili 1 , Yasmina Richa 1 , Patrick Collins 2 , Derek Hennessey 2 ¹School of Medicine, University College Cork, Cork, Ireland; ²Department of Urology, Mercy University … Hospital, Cork, Ireland BMC Proceedings 2025 , 19(2): OS4 Introduction: Large language models (LLMs) are artificial intelligence (AI) that use deep learning techniques to understand, summarize and generate content. …

Isatuximab: A Review in Transplant-Ineligible Newly Diagnosed Multiple Myeloma.

Isatuximab (isatuximab-irfc; SARCLISA®) is an anti-CD38 monoclonal antibody approved in the EU and the USA for use in combination with bortezomib, lenalidomide and dexamethasone for the treatment of adults with newly diagnosed multiple myeloma (NDMM) who are ineligible for autologous stem cell transplantation (ASCT). In a phase III study in this patient population, isatuximab-bortezomib-lenalidomide-dexamethasone significantly prolonged progression-free survival (PFS) and generally improved the depth of tumour response versus bortezomib-lenalidomide-dexamethasone. Overall survival (OS) data we

Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology.

Oleocanthal (OC), a secoiridoid phenolic compound exclusive to extra virgin olive oil (EVOO), has emerged as a promising nutraceutical with multifaceted anti-cancer properties. Despite its well-characterized anti-inflammatory and antioxidant effects, the mechanistic breadth and translational potential of OC in oncology remain underexplored and fragmented across the literature. This comprehensive review synthesizes and critically analyzes recent advances in the molecular, pharmacological, and translational landscape of OC's anti-cancer activities, providing an integrative framework to bridge pr

The Emerging Role of Interleukin-32 in HIV-Associated Cardiovascular Comorbidities: A Mini Review.

With the widespread use of antiretroviral therapy (ART), the life expectancy of people living with HIV (PLWH) has significantly improved. However, the incidence of cardiovascular disease (CVD) in this population has progressively increased. PLWH exhibit a significantly higher risk of cardiovascular diseases compared to the general population. Consequently, CVD has become one of the leading contributors to mortality not related to AIDS. The pathogenesis may involve several factors: HIV-related proteins exacerbating endothelial injury and inflammation; immune activation and chronic inflammation;

Impact of tele-exercise on quality of life, physical fitness, functional capacity and strength in different adult populations: a systematic review of clinical trials.

INTRODUCTION: This study aimed to review the impact of tele-exercise on different adult populations, comparing synchronous and asynchronous interventions and their effects on outcomes such as quality of life, physical fitness, functional capacity, strength, and pain. METHODS: Randomised clinical trials and quasi-experimental studies published between 2014 and 2024 were included, totalling 16 studies with 1,416 participants. The interventions varied between synchronous teleexercise (via videoconference) and asynchronous (via apps and recorded videos). The review followed the PRISMA guidelines,

The contributions of family care-givers at end of life: A national post-bereavement census survey of cancer carers' hours of care and expenditures.

BackgroundFamily members provide vital care at end of life, enabling patients to remain at home. Such informal care contributes significantly to the economy while supporting patients' preferences and government policy. However, the value of care-givers' contributions is often underestimated or overlooked in evaluations. Without information on the activities and expenditures involved in informal care-giving, it is impossible to provide an accurate assessment of carers' contribution to end-of-life care.AimThe aim of this study was to investigate the contributions and expenditure of informal, fam

Social Support in Older Adults With CKD: A Report From the CRIC (Chronic Renal Insufficiency Cohort) Study.

Rationale & objectiveSocial support in older adults with chronic kidney disease (CKD) is a potentially modifiable factor that may affect important clinical outcomes such as health-related quality of life, cognitive function, and frailty. However, limited data about the effects of social support in older patients with non-dialysis-dependent CKD exist. Our objective was to evaluate the association of social support with health-related quality of life, cognitive function, and frailty in older adults with CKD.Study designCross-sectional analysis of a prospective cohort study.Setting & population1,

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Issues in Oncology.

Several abstracts presented at the ASCO Annual Meeting reflected the meeting theme of providing high-quality care to every patient. Following coverage by The ASCO Post, Editor-in-Chief to JADPRO, Pamela Hallquist Viale, RN, MS, CNS, ANP, comments on abstracts revealing disparities afflicting both providers and patients in the cancer care community, as well as initiatives designed to combat them.

Факторы риска и клиническое воздействие боли в костях у пациентов с множественной миеломой - перспективное междисциплинарное исследование.

Боль в костях доходит до 80% :: количество пациентов с множественными миеломами (ММ) и значительно ухудшает качество жизни (КОЛ), однако его конкретные прогнозы по-прежнему плохо характеризуются. Определение факторов риска имеет важнейшее значение для раннего вмешательства и индивидуального лечения. МЕТОДЫ: Это перспективное исследование, рассчитанное на один центр 352 Пациенты. Боль в костях регистрируется с использованием стандартного вопросника. Для выявления независимых прогнозов боли в костях использовалась многовариантная логистическая регрессия с поэтапным отбором. QoL и состояние здоро

The experience of palliative patients and their families of a family meeting utilised as an instrument for spiritual and psychosocial care: A qualitative study.

BackgroundThis study explores the experience of palliative patients and their family members of a family meeting model, utilised as an instrument for the provision of spiritual and psychosocial care. In doing so the study embraces a broad understanding of spirituality which may or may not include formal religious practice and a concept of psychosocial care that includes: social and emotional well-being, communication, self esteem, mental health and adaptation to illness. The meeting of spiritual and psychosocial needs is considered to be an important aspect of palliative care.MethodsThis quali

Meeting the challenge of cancer survivorship in public health: results from the evaluation of the chronic disease self-management program for cancer survivors.

IntroductionSelf-management has been identified as an important opportunity to improve health outcomes among cancer survivors. However, few evidence-based interventions are available to meet this need.MethodsThe effectiveness of an adapted version of the Chronic Disease Self-Management Program for cancer survivors called Cancer Thriving and Surviving was evaluated in a randomized trial. Outcomes were assessed at baseline and 6-months post program via written survey among 244 participants in Colorado. Repeated measures analysis was used to analyze pre/post program change.ResultsStatistically si

Метаболизм триптофана в области диагностических и внегигиенических заболеваний: механизмы, клинические последствия и терапевтические перспективы.

Метаболизм триптофана (Trp) лежит на пересечении питания, микробиотики кишечника, мукосовой иммунологии и системных процессов воспаления, которые играют ключевую роль во многих желудочно-кишечных и внекишечных заболеваниях. Трап представляет собой важнейшую аминокислоту, получаемую с помощью рациона питания. Помимо своей роли в синтезе белка, он метаболизируется по трем основным направлениям: кинуреньиновый путь, серотонин/мелатонин, и микробный метаболизм в кишечнике, ведущий к индолу и связанным с ним производным. Кинуренинский путь представляет собой основной путь деградации Trp и тесно свя

Роль воспаления в нейродегенеративных болезнях: болезнь Паркинсона, болезнь Альцгеймера и множественный склероз.

Нейродегенеративные заболевания представляют собой группу заболеваний, которые, как правило, характеризуются постепенным повреждением и дегенерацией нейронов в центральной нервной системе. В эту группу входят болезнь Паркинсона, болезнь Альцгеймера и множественный склероз. В последние годы все больше фактов указывает на важную роль воспаления в патогенезе этих условий. Происхождение воспаления в мозге, которое часто вызывается провоспалительной активацией микроглий или астроцитов, может, следовательно, привести к хронической провокационной реакции, способствующей развитию нейродегенеративных п

Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myeloma.

Extramedullary disease (EMD) in multiple myeloma (MM) is associated with poor outcomes following B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR) T therapy, yet its impact on treatment-related toxicity remains unclear. This study evaluates the impact of active EMD on toxicity, efficacy, and survival in patients with MM treated with idecabtagene vicleucel (ide-cel) or ciltacabtagene autoleucel (cilta-cel). We conducted a retrospective cohort study of all patients with MM who received ide-cel (N=32) or cilta-cel (N=76) as standard-of-care therapy at our institution from

Морфологические изменения в сетчатке при расстройствах, связанных с употреблением алкоголя: систематический обзор и метаанализ исследований с использованием технологии оптической согласованности.

Цель обзора - использование чреонического алкоголя связано с различными структурными и функциональными изменениями в мозге. Скринальная морфология, оцениваемая с помощью оптической последовательности томографии (OCT), неинвазивно выявляет повреждения мозга, связанные с алкоголем, и может быть маркером болезней. 15/ Апрель/2025). Метаанализы случайного воздействия проводились по толщине параметров сетчатки как на диске, так и на макуле: слой волокна сетчатки (RNFL), слой ячеек ганглиона (GCL), внутренний плексиформный слой (IPL), плексиформальный слой с ганглионными клетками (GCIPL), толщина хо

FAST: быстрая, свободная, последовательная и неконтролируемая система сегментации и отслеживания олигодендроцитов.

Чтобы разработать репаративную терапию для неврологических расстройств, таких как множественный склероз (MS), нам нужно лучше понять физиологию потери и замены олигодендроцитов, клеток, которые делают миелин и являются объектом поражения в MS. В Vivo двухфотографическая флуоресцентная микроскопия позволяет непосредственно визуализировать олигодендроциты в нетронутом мозгу трансгенных моделей мыши, что позволяет глубже понять продольную динамику замены олигодендроцитов после повреждения. Однако задача отслеживания судьбы отдельных олигодендроцитов требует больших усилий для ручной аннотации и я

Health-related quality of life in patients with hematologic malignancies treated with chimeric antigen receptor T-cell therapy: review and current progress.

Chimeric antigen receptor (CAR) T-cell therapy has transformed the care of patients with relapsed/refractory B-cell-derived hematologic malignancies. To date, six CAR T-cell therapies, targeting either CD19 or B-cell maturation antigen, have received regulatory approval. Along with the promising survival benefit, CAR T-cell therapy is associated with potentially life-threatening adverse events, including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome. While clinical trials evaluating CAR T-cell therapy consistently report the incidence of these adverse eve